About this trial
Marfan syndrome (MFS) is a distinctive connective tissue disorder that affects multiple organ systems including the heart, bones, ligaments, and eyes, and is associated with significant risk of aortic dissection. Given limited evidence from in-vitro studies, and theoretical concerns, the majority of patients with MFS are restricted from certain physical activities. The lack of exercise and deconditioning have detrimental effects including increasing weakness, joint pain, decreased endurance, and depressive symptoms. Given the significant paucity of data currently existing on the effects of exercise in humans with MFS, and the recent, optimistic findings in rodent models, this pilot trial was established to assess the effects of moderated dynamic exercise in adolescents and young adults with MFS.
Eligibility criteria
Qualifiers
Male and female patients diagnosed with Marfan syndrome (defined by Ghent criteria and either a pathogenic variant in FBN1 or ectopia lentis)
Age 10-25 years at enrollment
Disqualifiers
History of aortic surgery
History of spinal surgery with implanted materials that may negatively impact MRI safety or imaging quality.
Diagnosis of major congenital heart disease (ASD, VSD, bicuspid aortic valve, and mitral valve prolapse will not qualify as exclusion criteria)
Condition limiting the ability to perform moderate exercise.
Trial design
Treatments tested in this trial
- Exercise Intervention Group
- Control Group
Treatment groups
Sponsors and collaborators
Baylor College of Medicine
Lead sponsor
Southern Star Research
Collaborator